Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro-oesophageal junction

被引:44
|
作者
Christensen, J. F. [1 ]
Simonsen, C. [1 ]
Brack-Petersen, A. [1 ]
Thorsen-Streit, S. [1 ]
Herrstedt, A. [1 ]
Djurhuus, S. S. [1 ]
Egeland, C. [2 ]
Mortensen, C. E. [3 ]
Kofoed, S. C. [2 ]
Kristensen, T. S. [4 ]
Garbyal, R. S. [5 ]
Pedersen, B. K. [1 ]
Svendsen, L. B. [2 ]
Hojman, P. [1 ]
de Heer, P. [2 ]
机构
[1] Rigshosp, Ctr Inflammat & Metab, Ctr Phys Act Res, Copenhagen, Denmark
[2] Rigshosp, Dept Surg Gastroenterol C, Copenhagen, Denmark
[3] Rigshosp, Dept Oncol, Copenhagen, Denmark
[4] Rigshosp, Dept Radiol, Copenhagen, Denmark
[5] Rigshosp, Dept Pathol, Copenhagen, Denmark
来源
BJS OPEN | 2019年 / 3卷 / 01期
关键词
PHYSICAL-ACTIVITY; CANCER PATIENTS; ESOPHAGEAL; CHEMORADIOTHERAPY; PREHABILITATION; CHEMOTHERAPY; THERAPY; RESECTION; RISK;
D O I
10.1002/bjs5.50110
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundNeoadjuvant chemotherapy or chemoradiotherapy is used widely before tumour resection in cancer of the gastro-oesophageal junction (GOJ). Strategies to improve treatment tolerability are warranted. This study examined the safety and feasibility of preoperative exercise training during neoadjuvant treatment in these patients. MethodsPatients were allocated to a standard-care control group or an exercise group, who were prescribed standard care plus twice-weekly high-intensity aerobic exercise and resistance training sessions. The primary endpoint was the incidence of serious adverse events (SAEs) that prevented surgery, including death, disease progression or physical deterioration. Preoperative hospital admission, postoperative complications, changes in patient-reported quality of life and pathological treatment response were also recorded. In the exercise group, adherence to exercise and changes in aerobic fitness, muscle strength and body composition were measured. ResultsThe incidence of SAEs was not increased in the exercise group. The risk of failure to reach surgery was 5 versus 21 per cent in the control group (risk ratio (RR) 023, 95 per cent c.i. 004 to 129), the risk of preoperative hospital admission was 15 versus 38 per cent respectively (RR 039, 012 to 123) and the risk of postoperative complications was 58 versus 57 per cent (RR 106, 061 to 173). The exercise group attended a mean of 175 sessions, and improved fitness, muscle strength and Functional Assessment of Cancer Therapy Esophageal (FACT-E) total score compared with the baseline level. ConclusionPreoperative exercise training during neoadjuvant treatment in patients with GOJ cancer is safe and feasible, with improvements in fitness, strength and quality of life. Preoperative exercise training may be associated with a lower risk of critical SAEs that preclude surgery or result in hospitalization.
引用
收藏
页码:74 / 84
页数:11
相关论文
共 26 条
  • [1] Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction
    de Manzoni, G
    Pedrazzani, C
    Pasini, F
    Durante, E
    Gabbani, M
    Grandinetti, A
    Guglielmi, A
    Griso, C
    Cordiano, C
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (06): : 506 - 510
  • [2] Preoperative chemoradiotherapy or perioperative chemotherapy for patients with gastro-oesophageal junction adenocarcinoma
    Ilson, David
    [J]. LANCET ONCOLOGY, 2023, 24 (06): : 593 - 595
  • [3] Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
    Villanueva, Luis
    Anabalon, Jaime
    Butte, Jean M.
    Salman, Pamela
    Panay, Sergio
    Milla, Elizabeth
    Gallardo, Carlos
    Hoefler, Sebastian
    Charles, Roberto
    Reyes, Felipe
    Barajas, Olga
    Matamala, Luis
    Molina, Angelica
    Portino, Sergio
    Berrios, Marcela
    Caglevic, Christian
    Mahave, Mauricio
    [J]. ECANCERMEDICALSCIENCE, 2021, 15
  • [4] Individualised surgical treatment of patients with an adenocarcinoma of the distal oesophagus or gastro-oesophageal junction
    Hulscher, JBF
    van Lanschot, JJB
    [J]. DIGESTIVE SURGERY, 2005, 22 (03) : 130 - 134
  • [5] Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives
    Birla, Rodica
    Hoara, Petre
    Achim, Florin
    Dinca, Valeriu
    Ciuc, Diana
    Constantinoiu, Silviu
    Constantin, Adrian
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (10) : 1675 - 1690
  • [6] Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours
    Thomaschewski, Michael
    Hummel, Richard
    Petrova, Ekaterina
    Knief, Juliana
    Wellner, Ulrich Friedrich
    Keck, Tobias
    Bausch, Dirk
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (13) : 1429 - 1439
  • [7] Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours
    Michael Thomaschewski
    Richard Hummel
    Ekaterina Petrova
    Juliana Knief
    Ulrich Friedrich Wellner
    Tobias Keck
    Dirk Bausch
    [J]. World Journal of Gastroenterology, 2018, (13) : 1429 - 1439
  • [8] A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma
    Mirza, A.
    Brown, M.
    McNulty, C.
    Valentine, J.
    Annesley, A.
    Galloway, S.
    Welch, I.
    West, C. M.
    Pritchard, S.
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [9] A pilot study to investigate of the role of thymidylate synthase as a marker of response to neoadjuvant chemotherapy in gastric and gastro-oesophageal junction adenocarcinoma
    Mirza, A.
    Pritchard, S.
    Galloway, S.
    West, C.
    Welch, I.
    [J]. BRITISH JOURNAL OF SURGERY, 2012, 99 : 90 - 90
  • [10] Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
    Klevebro, F.
    Johnsen, G.
    Johnson, E.
    Viste, A.
    Myrnas, T.
    Szabo, E.
    Jacobsen, A. -B.
    Friesland, S.
    Tsai, J. A.
    Persson, S.
    Lindblad, M.
    Lundell, L.
    Nilsson, M.
    [J]. EJSO, 2015, 41 (07): : 920 - 926